Menu
Back to Journals » Drug Design, Development and Therapy » Volume 11
Original Research
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,142 | Dovepress* | 10,225+ | 1,438 | 11,663 | |
| PubMed Central* | 917 | 341 | 1,258 | ||
| Totals | 11,142 | 1,779 | 12,921 | ||
| *Since 3 April 2017 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 1 | 0 | 0 | 2 | 5 |
View citations on PubMed Central and Google Scholar